Drug Product Recalls in 2014 Categorized by Problem Area
This article was originally published in The Gold Sheet
Executive Summary
This comprehensive table provides key facts at a glance for every one of the 1,335 drug recalls FDA reported last year, grouped into seven main problem areas. For each recall, it says what product was recalled, what company manufactured it and recalled it, how seriously FDA rated the health threat the recalled product posed, and what reason the company gave for recalling the product.
You may also be interested in...
KVK Research Pleads Guilty To Adulterated Drug Distribution
KVK Research and KVK Tech failed to notify the US FDA about the use of a foreign API manufacturing facility and submitted alleged false claims to governmental health programs.
2014 Drug Recalls: Contamination Surge Enters Fifth Year
Microbial and particulate contamination drove drug recalls to historic levels for a fifth year in 2014, FDA recall data shows. But the data still falters in identifying the weakest links in global pharmaceutical supply chain quality.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.